Columbia Sues Illumina for Infringement of NGS Patents
March 26, 2012
Columbia Sues Illumina for Infringement of NGS Patents
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News - Resurgence in HiSeq Sales Helps Drive Illumina Revenue Growth in Q1 2013
April 23, 2013 / In Sequence - MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing
January 29, 2013 / In Sequence - Researchers Rank MiSeq over PGM for Usability; Expect Their Sequencing Output to Grow by Half in 2013
January 22, 2013 / In Sequence - Illumina Acquires Moleculo, Plans to Increase MiSeq Reads to 400 Bases, Opens New Sequencing Facility
January 8, 2013 / In Sequence